US 11459323
Monocyclic β-lactam compound for treating bacterial infection
granted A61PA61P11/00A61P31/04
Quick answer
US patent 11459323 (Monocyclic β-lactam compound for treating bacterial infection) held by Medshine Discovery Inc. expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P11/00, A61P31/04